Evermore Chemical Industry Co., Ltd. AI Stock Analysis
Evermore Chemical Industry Co., Ltd. (1735) AI Stock Analysis
Evermore Chemical Industry Co., Ltd.
(TWSE:1735)
Evermore Chemical scores in the below-average range. The dominant drag is deteriorating earnings power — declining revenue, an operating margin squeezed to 2.3%, EBITDA down sharply and ROE of just 5.0% — which leaves little cushion in a soft chemicals cycle. Offsetting this are genuine balance sheet progress (debt down more than 40% since 2021, leverage at 0.64x equity) and solid cash conversion, with free cash flow of NT$173 million exceeding reported profit. Technicals add further caution, with the share price below all major moving averages and negative MACD momentum. Valuation is the most supportive element: a 3.43% dividend yield and a fair 17x P/E, though the multiple is not compelling given shrinking profits. Key things to watch are revenue stabilization, EBITDA recovery and continued debt reduction.
Evermore Chemical Industry Co., Ltd. (1735) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.93B
- Dividend Yield
- 3.37%
- Average Volume (3M)
- 194.73K
- Price to Earnings (P/E)
- 16.5
- Beta (1Y)
- 0.72
- Revenue Growth
- 1.82%
- EPS Growth
- 132.90%
- Country
- TW
- Employees
- 408
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Evermore Chemical Industry Co., Ltd. Business Overview & Revenue Model
Company Description
Evermore Chemical Industry Co., Ltd. is a global manufacturer and supplier specializing in polyurethane (PU) resins, particularly for synthetic leather applications, serving markets in China, Taiwan, and internationally. Its extensive product catalog...
Evermore Chemical Industry Co., Ltd. Financial Statement Overview
Summary
Mixed profile. The income statement is the weak link (score 42): revenue slipped to NT$2.30 billion from NT$2.65 billion, operating margin compressed to 2.3% from 5.7%, EBITDA nearly halved to NT$164 million and net income fell about 19% to NT$78 million, leaving a thin 3.4% net margin despite a modest gross margin improvement to 18.1%. The balance sheet is healthier (score 60): debt has been cut four years running to NT$1.00 billion and debt-to-equity is down to 0.64, though borrowings still equal roughly six times EBITDA and ROE is only 5.0%. Cash flow is the strongest area (score 65): operating cash flow of NT$213 million comfortably exceeded net income and free cash flow improved to NT$173 million, supporting ongoing deleveraging — though cash generation has trended down from NT$457 million in 2023.
Income Statement
42NeutralBalance Sheet
60NeutralCash Flow
65Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.38B | 2.30B | 2.65B | 2.37B | 2.96B | 3.20B |
| Gross Profit | 454.72M | 417.65M | 469.33M | 439.85M | 386.01M | 433.19M |
| EBITDA | 201.50M | 164.46M | 264.01M | 227.38M | 175.82M | 125.48M |
| Net Income | 116.21M | 77.62M | 96.41M | 75.22M | 35.21M | 10.06M |
Balance Sheet | ||||||
| Total Assets | 3.10B | 2.96B | 3.28B | 3.30B | 3.39B | 3.72B |
| Cash, Cash Equivalents and Short-Term Investments | 455.44M | 410.90M | 359.57M | 389.64M | 232.00M | 298.81M |
| Total Debt | 1.00B | 996.21M | 1.22B | 1.34B | 1.51B | 1.78B |
| Total Liabilities | 1.56B | 1.40B | 1.71B | 1.80B | 1.89B | 2.28B |
| Stockholders Equity | 1.54B | 1.55B | 1.57B | 1.50B | 1.50B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 173.61M | 172.63M | 142.37M | 371.40M | 244.63M | -730.15M |
| Operating Cash Flow | 204.38M | 212.71M | 238.54M | 456.88M | 340.90M | -243.57M |
| Investing Cash Flow | 155.57M | 142.31M | -96.10M | -86.24M | -77.74M | -488.53M |
| Financing Cash Flow | -342.67M | -304.63M | -175.49M | -160.29M | -315.33M | 661.01M |
Evermore Chemical Industry Co., Ltd. Peers Comparison
Overall Rating
TW:696763Neutral
TW:174256Neutral
TW:173553Neutral
TW:132351Neutral
TW:893539Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | TWD 1.93B | 12.15 | ― | 5.44% | 22.39% | 53.47% | |
| 56Neutral | TWD 1.99B | -40.88 | ― | ― | -39.62% | 56.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | TWD 1.90B | 16.50 | ― | 3.37% | 1.82% | 132.90% | |
| 51Neutral | TWD 1.99B | 17.09 | ― | 4.15% | -3.86% | -37.34% | |
| 39Underperform | TWD 1.96B | -28.69 | ― | ― | -13.84% | 12.29% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1735 | Evermore Chemical Industry Co., Ltd. | 19.30 | 4.87 | 33.72% | |
| TW:1323 | Yonyu Plastics Co., Ltd | 21.70 | 2.99 | 15.98% | |
| TW:1742 | Taiwan Wax Co., Ltd. | 21.20 | 7.50 | 54.74% | |
| TW:6967 | Trans-Sun Materials Technology Co., Ltd. | 65.40 | 9.77 | 17.55% | |
| TW:7879 | Advanced Material Systems Corp | 54.30 | -94.62 | -63.54% | |
| TW:8935 | Pontex Polyblend Co. Ltd. | 17.40 | -1.25 | -6.70% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
